BIOMAT Database Logo BIOMAT Database Logo

[Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders]. 1990

Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
Third Department of Internal Medicine, School of Medicine, Yamaguchi University.

Clinical and bacteriological efficacies of sulbactam/cefoperazone (SBT/CPZ) were studied in 44 patients with serious infections associated with hematological malignancy. 1. SBT/CPZ was clinically effective in 33 cases (76.7%). Excellent effects were obtained in 23 cases, good effects in 10 cases and fairly good effects in 7 cases. Clinical effectiveness of SBT/CPZ was not dependent on neutrophil number in peripheral blood. 2. Bacteriologically SBT/CPZ was effective against all of the isolated organisms from 21 cases. 3. Adverse reactions were not significant except one case with eruption, 2 cases with abnormalities in hepatic function tests and 3 cases with abnormalities in renal function tests.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[Clinical experience of chemotherapy with cefmetazole for severe infections accompanying malignant hematological disorders].
March 1989, The Japanese journal of antibiotics,
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
September 1991, The Japanese journal of antibiotics,
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
August 1992, The Japanese journal of antibiotics,
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
August 1989, The Japanese journal of antibiotics,
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
October 1993, The Japanese journal of antibiotics,
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[Chemotherapy with imipenem/cilastatin for severe infections accompanied by malignant hematological disorders].
March 1993, The Japanese journal of antibiotics,
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
September 1994, The Japanese journal of antibiotics,
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
January 2005, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
April 1995, The Japanese journal of antibiotics,
Y Fujii, and H Ayame, and H Inoue, and N Fujita, and K Miyoshi, and K Murano, and K Hatao, and K Yaga, and K Kaku, and T Kaneko
[A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
March 1993, The Japanese journal of antibiotics,
Copied contents to your clipboard!